Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report
This study group has been evaluating MediWound's enzymatic agent for the debridement of deep burn wounds for over 15 years. This publication summarizes their observations.
Rosenberg et al. Burns. 2004 Dec;30(8):843-50

Escharotomy using an enzymatic debridement agent for treating experimental burn-induced compartment syndrome in an animal model
This study assesses the efficacy of MediWound's enzymatic agent for treating burn induced compartment syndrom (BICS) using a pig model
Krieger et al. J Trauma. 2005 Jun;58(6):1259-64

Early nonsurgical removal of chemically injured tissue enhances wound healing in partial thickness burns
The study examined several treatment modalities for partial thickness chemical burns. Of those, MediWound's enzymatic agent was the more effective than surgical excision, laser ablation or trypsin-linked to gauze.
Eldad et al. Burns. 1998; 24(2): 166-172